Video Center


The OBR Video Center Features educational videos covering a wide range of oncology specific topics.

Richard Finn, MD, outlines the role of TACE with systemic therapy in HCC

Dr. Finn, Professor of Clinical Medicine, Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine, UCLA, outlines the role of TACE with systemic therapy in hepatocellular carcinoma (HCC)

Tags: ASCO GI Conference CoverageLiver (includes HCC, Billiary Tract)

Published: 04 February 2019

Recent Videos

video

Andres Poveda, MD, discusses take home message regarding maintenance in ovarian cancer management

Dr. Poveda, Medical Coordinator, Quirónsalud Hospital, discusses the take home message for medical oncologists regarding maintenance in the management of ...

video

Constantine Tam, MD & Robert Figlin, MD discuss progress in Waldenstrom’s Macroglobulinemia & ASCO20

Constantine Tam, MD of Peter MacCallum Cancer Center and Robert Figlin, MD of Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai ...

video

Andres Poveda, MD, considers BRCA mutation & homologous recombination deficiency regarding treatment

Dr. Poveda, Medical Coordinator, Quirónsalud Hospital, considers the BRCA mutation and homologous recombination deficiency when making decisions regarding the treatment ...

video

Andres Poveda, MD, shares design and outcomes of the PHASE 3 SOLO2 study regarding ovarian cancer

Dr. Poveda, Medical Coordinator, Quirónsalud Hospital, shares the design and outcomes of the Phase 3 SOLO2 clinical study investigating the ...

video

Tanios Bekaii-Saab, MD, FACP, considers the emerging role of immunotherapy in advanced CRC treatment

Dr. Bekaii-Saab, Professor of Gastrointestinal Cancer, Mayo Clinic, considers the emerging role of immunotherapy in the treatment of advanced colorectal ...

video

Tanios Bekaii-Saab, MD, FACP, discusses oral chemotherapy in adjuvant and advanced CRC treatment during the COVID era

Dr. Bekaii-Saab, Professor of Gastrointestinal Cancer, Mayo Clinic, discusses oral chemotherapy in the treatment of adjuvant and advanced colorectal cancer ...

video

Thierry Andre, MD, on evolution of I-O towards the first line treatment of colorectal cancer

Dr. Andre, Professor of Medical Oncology, Sorbonne University, discusses the evolution of I-O towards the first line treatment in colorectal ...

video

Thierry Andre, MD, provides thoughts on how to identify patients with CRC unlikely to respond to I-O

Dr. Andre, Professor of Medical Oncology, Sorbonne University, provides thoughts on how to identify patients with colorectal cancer that are ...

video

Thierry Andre, MD, shares design of the Keynote-177 study in metastatic colorectal cancer

Dr. Andre, Professor of Medical Oncology, Sorbonne University, shares the design of the Keynote-177 study investigating the use of pembrolizumab ...

video

Thierry Andre, MD, regarding the outcomes of the Keynote-177 study in metastatic colorectal cancer

Dr. Andre, Professor of Medical Oncology, Sorbonne University, regarding the outcomes of the Keynote-177 study investigating the use of pembrolizumab ...

Related Videos

video-image

Tanios Bekaii-Saab, MD, FACP, discusses oral chemotherapy in adjuvant and advanced CRC treatment during the COVID era

video-image

Tanios Bekaii-Saab, MD, FACP, considers the emerging role of immunotherapy in advanced CRC treatment

video-image

Andres Poveda, MD, shares design and outcomes of the PHASE 3 SOLO2 study regarding ovarian cancer

video-image

Andres Poveda, MD, considers BRCA mutation & homologous recombination deficiency regarding treatment

video-image

Constantine Tam, MD & Robert Figlin, MD discuss progress in Waldenstrom’s Macroglobulinemia & ASCO20

video-image

Andres Poveda, MD, discusses take home message regarding maintenance in ovarian cancer management

video-image

Roy Herbst, MD, PhD, shares perspective on the plenary session presentation of the ADAURA study

video-image

Thierry Andre, MD, provides thoughts on how to identify patients with CRC unlikely to respond to I-O

video-image

Shaji Kumar, MD, shares results of the Phase 3 study regarding 1st line multiple myeloma treatment

video-image

Thierry Andre, MD, on evolution of I-O towards the first line treatment of colorectal cancer

video-image

Joyce Liu, MD, summarizes outcomes of the NRG-GY004 phase III study regarding ovarian cancer

video-image

Bruce Feinberg, DO, on the understanding medical oncologists have on social determinants of health

video-image

Matthew Galsky, MD, tells us about the Phase 3 IMvigor130 study in advanced urothelial cancer

video-image

Matthew Galsky, MD, explains which biomarkers likely have the most predictive value

video-image

Matthew Galsky, MD, shares the design and outcomes of the Javelin Bladder 100 study

video-image

Matthew Galsky, MD, considers a new standard of maintenance with the Javelin study outcomes

video-image

Matthew Galsky, MD, discusses how to identify patients that will likely be good responders for I-O

video-image

Thierry Andre, MD, regarding the outcomes of the Keynote-177 study in metastatic colorectal cancer

video-image

Xiuning Le, MD, PhD, discusses goals and results of the VISION study in non-small cell lung cancer

video-image

Thierry Andre, MD, shares design of the Keynote-177 study in metastatic colorectal cancer